Trending

Santhera

EU regulators reject Santhera’s Raxone for DMD

EU regulators reject Santhera’s Raxone for DMD

Swiss company to appeal regulators’ decision.

X

EU regulators reject Santhera’s Raxone for DMD

https://pharmaphorum.com/news/eu-regulators-reject-santheras-raxone-dmd/

UK patients gain early access to Duchenne drug

UK patients gain early access to Duchenne drug

Patients to get Santhera’s Raxone under EAMS scheme.

X

UK patients gain early access to Duchenne drug

https://pharmaphorum.com/news/uk-patients-get-early-access-duchenne-drug/

Santhera DMD drug has setback in US

Santhera DMD drug has setback in US

Approval unlikely before 2020.

X

Santhera DMD drug has setback in US

https://pharmaphorum.com/news/santhera-dmd-drug-has-setback-in-us/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com